NanoString Technologies, Inc. (NASDAQ:NSTG) updated its FY17 earnings guidance on Thursday. The company provided EPS guidance of ($1.99-1.86) for the period, compared to the Thomson Reuters consensus EPS estimate of ($2.10). The company issued revenue guidance of $109-112 million, compared to the consensus revenue estimate of $110.55 million.

NSTG has been the subject of several analyst reports. Robert W. Baird reissued a buy rating and issued a $14.00 target price on shares of NanoString Technologies in a research note on Tuesday, October 24th. Zacks Investment Research downgraded shares of NanoString Technologies from a hold rating to a sell rating in a research note on Tuesday, October 17th. Janney Montgomery Scott downgraded shares of NanoString Technologies from a buy rating to a neutral rating in a research note on Thursday, October 12th. Cowen and Company downgraded shares of NanoString Technologies from an outperform rating to a market perform rating in a research note on Thursday, October 12th. Finally, BidaskClub downgraded shares of NanoString Technologies from a sell rating to a strong sell rating in a research note on Friday, July 28th. Three investment analysts have rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the company’s stock. NanoString Technologies currently has a consensus rating of Hold and a consensus price target of $17.75.

NanoString Technologies (NASDAQ:NSTG) last released its quarterly earnings results on Tuesday, August 8th. The biotechnology company reported ($0.20) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.37) by $0.17. NanoString Technologies had a negative return on equity of 329.59% and a negative net margin of 44.28%. The business had revenue of $34.59 million during the quarter, compared to analyst estimates of $29.87 million.

TRADEMARK VIOLATION WARNING: “NanoString Technologies, Inc. (NSTG) Issues FY17 Earnings Guidance” was first reported by American Banking News and is the property of of American Banking News. If you are viewing this report on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The correct version of this report can be accessed at https://www.americanbankingnews.com/2017/11/02/nanostring-technologies-inc-nstg-issues-fy17-earnings-guidance.html.

NanoString Technologies Company Profile

NanoString Technologies, Inc develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample.

Receive News & Ratings for NanoString Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.